This can be life changing-To The Moon - Tiger Brokers Online Investing Community - To The Moon

Like
Comment
Favorite

LEAP AHEAD
11-09

This can be life changing

Genprex Inc expected to post a loss of $1.93 a share - Earnings Preview

* Genprex Inc is expected to show no change in quarterly revenue when it reports results on November 12 (estimated) for the period ending September 30 2024 * * LSEG's mean analyst estimate f

Genprex Inc expected to post a loss of $1.93 a share - Earnings Preview

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Like

Report

Comment

Top
Latest

empty

No comments yet

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":368867446006112,"tweetId":"368867446006112","gmtCreate":1731097077914,"gmtModify":1731097082782,"author":{"id":4133999747533962,"idStr":"4133999747533962","authorId":4133999747533962,"authorIdStr":"4133999747533962","name":"LEAP AHEAD","avatar":"https://community-static.tradeup.com/news/7a0420cfc9f1f2d59cd60355ccc7c56e","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"f00de38e20574ad1abf55a15966547c8-3","templateUuid":"f00de38e20574ad1abf55a15966547c8","name":"Average winning trade","description":"Top 20%","bigImgUrl":"https://community-static.tradeup.com/news/a1941f6be974173f1730be2ac51aabb7","smallImgUrl":"https://community-static.tradeup.com/news/df2d04ef8434cb0d3a8571ada46fffd0","grayImgUrl":"https://community-static.tradeup.com/news/b231d6c35e6f28d4132f36c047c50ea0","redirectLinkEnabled":0,"redirectLink":"https://www.tigerbrokers.com.sg/activity/market/2023/stock-contest?adcode=StockContest2023","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.22","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":7,"starInvestorFlag":false},"themes":[],"images":[{"img":"https://community-static.tradeup.com/news/92232170c5f181a776dafab253e33864"}],"coverImages":[{"img":"https://community-static.tradeup.com/news/92232170c5f181a776dafab253e33864"}],"html":"<html><head></head><body><p>This can be life changing&nbsp;</p><t-t type=\"img\" src=\"https://community-static.tradeup.com/news/92232170c5f181a776dafab253e33864\"></t-t></body></html>","htmlText":"<html><head></head><body><p>This can be life changing&nbsp;</p><t-t type=\"img\" src=\"https://community-static.tradeup.com/news/92232170c5f181a776dafab253e33864\"></t-t></body></html>","text":"This can be life changing","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/368867446006112","repostId":2481483234,"repostType":2,"repost":{"id":"2481483234","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1731081189,"share":"https://www.laohu8.com/m/news/2481483234?lang=&edition=full","pubTime":"2024-11-08 23:53","market":"us","language":"en","title":"Genprex Inc    expected to post a loss of $1.93 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2481483234","media":"Reuters","summary":"* Genprex Inc     is expected to show no change in quarterly revenue when it reports  results on November 12 (estimated) for the period ending September 30 2024   *    * LSEG's mean analyst estimate f","content":"<html><body><p>* Genprex Inc     is expected to show no change in quarterly revenue when it reports  results on November 12 (estimated) for the period ending September 30 2024</p><p>   * </p><p>   * LSEG's mean analyst estimate for Genprex Inc is for a loss of $1.93 per share. </p><p>   * The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 2 \"strong buy\" or \"buy,\" no \"hold\" and no \"sell\" or \"strong sell.\"  </p><p>   * The mean earnings estimate of analysts was unchanged in the last three months. </p><p>   * Wall Street's median 12-month price target for Genprex Inc is 8.75, above its last closing price of $1.69. </p><p>This summary was machine generated November 8 at 15:52 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Genprex Inc    expected to post a loss of $1.93 a share - Earnings Preview</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGenprex Inc    expected to post a loss of $1.93 a share - Earnings Preview\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2024-11-08 23:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>* Genprex Inc     is expected to show no change in quarterly revenue when it reports  results on November 12 (estimated) for the period ending September 30 2024</p><p>   * </p><p>   * LSEG's mean analyst estimate for Genprex Inc is for a loss of $1.93 per share. </p><p>   * The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 2 \"strong buy\" or \"buy,\" no \"hold\" and no \"sell\" or \"strong sell.\"  </p><p>   * The mean earnings estimate of analysts was unchanged in the last three months. </p><p>   * Wall Street's median 12-month price target for Genprex Inc is 8.75, above its last closing price of $1.69. </p><p>This summary was machine generated November 8 at 15:52 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GNPX":"Genprex, Inc."},"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2481483234","content_text":"* Genprex Inc     is expected to show no change in quarterly revenue when it reports  results on November 12 (estimated) for the period ending September 30 2024   *    * LSEG's mean analyst estimate for Genprex Inc is for a loss of $1.93 per share.    * The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 2 \"strong buy\" or \"buy,\" no \"hold\" and no \"sell\" or \"strong sell.\"     * The mean earnings estimate of analysts was unchanged in the last three months.    * Wall Street's median 12-month price target for Genprex Inc is 8.75, above its last closing price of $1.69. This summary was machine generated November 8 at 15:52 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)","news_type":1},"isVote":1,"tweetType":1,"viewCount":73,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":21,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}